This new aspect of dysferlin biology, with the implications for the pathology of dysferlinopathies, indicates potential novel therapeutic avenues that could decisively complement existing strategies aimed at restoring membrane repair. Here, DYSF is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.